SOURCE: IBC Life Sciences

May 04, 2007 09:00 ET

Partnering, Licensing & Outsourcing From R&D to Clinical Trials to Be Addressed at IBC Life Sciences' Annual Drug Discovery Technology™: China 2007 R&D Summit

The China 2007 R&D Summit Will Be Held June 4-7, 2007 at the Grand Hyatt Hotel in Shanghai, China

WESTBOROUGH, MA -- (MARKET WIRE) -- May 4, 2007 -- The second international China 2007 R&D Summit is a forum for researchers and executives who are thinking of exploring business collaboration opportunities in China's fast-growing life sciences industry. This year's agenda includes 60 industry experts covering their perspectives on how to leverage drug discovery partnerships in China and how to stay ahead of your competition.

The China R&D Summit keynote presentations will provide advice from case studies and success stories derived from the regional partnerships and experiences of Pfizer, SiBiono, Novartis, Organon, and Pierre Fabre.

--  Phil Vickers, Ph.D. Pfizer, Inc
    Global Drug Discovery Partnerships – From Technologies to Therapies
--  Zhaohui Peng, Ph.D. Sibiono GeneTech Co. Ltd.
    The Current State of Gene Therapy in China
--  En Li, Ph.D. Novartis Institute of Biomedical Research
    Incorporating China as part of Novartis’ Global R&D Strategies
--  C. David Nicholson, Ph.D. Organon International
    Organon’s Exploration in China
--  Jean Deregnaucourt, Ph.D. Pierre Fabre Laboratories, S.A.
    Chinese and French Converging Interest in Traditional Chinese
    Medicine Research and Development: The Case of Pierre Fabre
    Laboratories Partnerships

The China R&D Summit will also include 5 panel discussions:

--  VC Investments & M&As in China - Understanding the State of the
    Industry in the Eyes of Investors
--  Current Trends in Pharma Discovery and Biology Research in China
--  Safety Pharmacology in PreClinical Drug Development of Small Molecules
    Pharmaceuticals and Biotherapeutic Proteins
--  Patent Issues Facing Pharmaceutical Companies in China
--  Issues with Clinical Research in China

There will be an optional pre-conference workshop on GLP in China: Current and Future Prospects. This workshop will cover the state of the art of preclinical GLP practices in China, and how they currently compare from a technical and regulatory perspective to the US and EU.

Review the full brochure at

Contact Information